U.S. Markets open in 7 hrs 49 mins
  • S&P Futures

    3,635.25
    +2.50 (+0.07%)
     
  • Dow Futures

    29,995.00
    -3.00 (-0.01%)
     
  • Nasdaq Futures

    12,110.75
    +34.75 (+0.29%)
     
  • Russell 2000 Futures

    1,853.00
    +1.50 (+0.08%)
     
  • Crude Oil

    45.24
    +0.33 (+0.73%)
     
  • Gold

    1,802.90
    -1.70 (-0.09%)
     
  • Silver

    23.20
    -0.09 (-0.41%)
     
  • EUR/USD

    1.1898
    +0.0001 (+0.0119%)
     
  • 10-Yr Bond

    0.8820
    0.0000 (0.00%)
     
  • Vix

    21.64
    -1.02 (-4.50%)
     
  • GBP/USD

    1.3340
    -0.0019 (-0.1414%)
     
  • USD/JPY

    104.5150
    +0.0350 (+0.0335%)
     
  • BTC-USD

    18,855.12
    -213.37 (-1.12%)
     
  • CMC Crypto 200

    374.61
    +4.86 (+1.31%)
     
  • FTSE 100

    6,432.17
    +98.33 (+1.55%)
     
  • Nikkei 225

    26,296.86
    +131.27 (+0.50%)
     

Novo Nordisk says Saxenda obesity drug to cost $1,068 per month

COPENHAGEN, April 22 (Reuters) - Novo Nordisk's new obesity drug Saxenda, which has been launched in the United States on Wednesday, will cost $1,068 per month in the country, the company told Reuters in an email on Wednesday.

"The amount paid by the individual patient will depend on whether Saxenda is covered by the person's health insurance," a Novo Nordisk spokesman said in the email.

(Reporting by Teis Jensen; Editing by Mark Potter)